NCT03358849View on ClinicalTrials.gov

"Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell (SMT-NK) Cell Therapy in Advanced Biliary Tract Cancer"

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

September 27, 2018

Study Completion Date

September 27, 2018

Conditions
Advanced Biliary Tract Cancer
Interventions
BIOLOGICAL

Natural killer cell

Patients who received natural killer cell injection

Trial Locations (1)

03722

Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03358849 - "Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell (SMT-NK) Cell Therapy in Advanced Biliary Tract Cancer" | Biotech Hunter | Biotech Hunter